Last reviewed · How we verify
Beclipur (BECLOBRATE)
Beclometasone dipropionate, also known as Beclomethasone or Beclometasone dipropionate, is a corticosteroid medication. It is a small molecule modality that works by reducing inflammation in the body. Beclometasone dipropionate is used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It is a patented medication, and its commercial status is not off-patent. Key safety considerations include potential side effects such as oral thrush and glaucoma.
At a glance
| Generic name | BECLOBRATE |
|---|---|
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Beclipur CI brief — competitive landscape report
- Beclipur updates RSS · CI watch RSS